One would assume that oncologists with bile tract cancer patients would be lining up to get them enrolled in this trial given the current treatment regime prospects - what do they have to lose ?
Well done team Imugene for moving things forward at such a rapid pace
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $135.5K | 9.771M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 74 | 19074337 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 6715476 | 14 |
View Market Depth
| Last trade - 11.36am 18/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |